Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer
Condition: HER2-positive Breast Cancer Interventions: Other: RNA sequencing; Other: Transcriptome analysis; Drug: Trastuzumab; Drug: Chemotherapy Sponsors: Omicsway Corporation; Oncobox Ltd., Russia; Vitamed, Russia; Republican Oncological Dispensary of Karelia Republic, Russia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Herceptin | Russia Health